AnaptysBio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

AnaptysBio Stock Summary

AnaptysBio competes with Crinetics Pharmaceuticals, Rhythm Pharmaceuticals, Kura Oncology, and CytomX Therapeutics. AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California. Anaptysbio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

AnaptysBio Key Financial Ratios

AnaptysBio Key Balance Sheet Accounts

AnaptysBio Key Income Statement Accounts

AnaptysBio Key Cash Accounts

AnaptysBio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AnaptysBio's current stock value. Our valuation model uses many indicators to compare AnaptysBio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AnaptysBio competition to find correlations between indicators driving AnaptysBio's intrinsic value. More Info.AnaptysBio is rated fifth in return on equity category among its peers. It is rated second in return on asset category among its peers . At present, AnaptysBio's Return On Equity is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AnaptysBio's earnings, one of the primary drivers of an investment's value.

AnaptysBio Systematic Risk

Today, most investors in AnaptysBio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AnaptysBio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of AnaptysBio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of AnaptysBio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AnaptysBio. We use our internally-developed statistical techniques to arrive at the intrinsic value of AnaptysBio based on widely used predictive technical indicators. In general, we focus on analyzing AnaptysBio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AnaptysBio's daily price indicators and compare them against related drivers.

When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.